160
Participants
Start Date
December 5, 2022
Primary Completion Date
June 1, 2028
Study Completion Date
August 31, 2028
Electric and acoustic stimulation (EAS) technology in the implanted ear(s)-this is the combination of a cochlear implant (CI) and hearing aid (HA) in the implanted ear(s)
This is a clinical fitting of an FDA approved EAS system for study participants that have received or who are scheduled to receive a CI based on clinical recommendations (i.e. not study related). The investigators will activate the CI sound processor's integrated HA circuit to allow for low-frequency acoustic amplification and mid-to-high frequency electric stimulation in the implanted ear(s) using recommended and accepted clinical practices and audiologic verification. EAS fitting will be completed using FDA approved clinical software and thereby is within the electrical and clinical specifications of the FDA approved device and accompanying software.
COMPLETED
Vanderbilt University Medical Center, Nashville
RECRUITING
University Of Wisconsin Madison, Madison
RECRUITING
Hearts for Hearing, Edmond
RECRUITING
University Of Texas at Austin, Austin
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
Hearts for Hearing
OTHER